Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells - Wikidata - wikimedia - TriplyDB

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

http://www.wikidata.org/entity/Q35166506

about

Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease Update on mesenchymal stem cell-based therapy in lupus and scleroderma Concise review: bone marrow autotransplants for liver disease?Progress of mesenchymal stem cell therapy for neural and retinal diseases Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials Characterization and profiling of immunomodulatory genes of equine mesenchymal stromal cells from non-invasive sources.Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential Different culture conditions modulate the immunological properties of adipose stem cells.Mesenchymal stem cells from fetal heart attenuate myocardial injury after infarction: an in vivo serial pinhole gated SPECT-CT study in rats Toll like receptor 3 & 4 responses of human turbinate derived mesenchymal stem cells: stimulation by double stranded RNA and lipopolysaccharide Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.Comparative Ability of Mesenchymal Stromal Cells from Different Tissues to Limit Neutrophil Recruitment to Inflamed Endothelium Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses.Integrated transcriptomic and proteomic analysis of the molecular cargo of extracellular vesicles derived from porcine adipose tissue-derived mesenchymal stem cells The Role of Cathelicidin LL-37 in Cancer Development.Comparative Evaluation of Human Mesenchymal Stem Cells of Fetal (Wharton's Jelly) and Adult (Adipose Tissue) Origin during Prolonged In Vitro Expansion: Considerations for Cytotherapy Cell therapy for full-thickness wounds: are fetal dermal cells a potential source?A New Method for Preparing Mesenchymal Stem Cells and Labeling with Ferumoxytol for Cell Tracking by MRI Dickkopf-1 has an Inhibitory Effect on Mesenchymal Stem Cells to Fibroblast Differentiation.The Necessity of a Systematic Approach for the Use of MSCs in the Clinical Setting Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study.Progenitor cells for ocular surface regenerative therapy.Perspectives on the use of stem cells for autism treatment DNA Methylation Changes during In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability?Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application.Immunomodulation in stem cell differentiation into neurons and brain repair.Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.Human bone marrow stromal cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation.Mesenchymal Stem Cell Treatment of Inflammation-Induced Cancer.Molecular and Cellular Interactions of Allogenic and Autologus Mesenchymal Stem Cells with Innate and Acquired Immunity and Their Role in Regenerative Medicine.Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study.Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis.Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.Positron emission tomography-computer tomography scan used as a monitoring tool following cellular therapy in cerebral palsy and mental retardation-a case report.Clonal populations of amniotic cells by dilution and direct plating: evidence for hidden diversity.Comparison of proliferative and multilineage differentiation potential of sheep mesenchymal stem cells derived from bone marrow, liver, and adipose tissue Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.

P2860

Q26746977-F280714F-7E5E-4E83-B920-880F0284A33D Q26769618-D0C7C7F1-E815-4861-86F6-CFAD3984E120 Q26777402-3CB11995-DB72-4EF0-8029-133F0D9A8F17 Q27010009-CDF4AF8D-605B-4976-9386-C5A4AF153C78 Q27015716-233EF91C-F857-48B8-8B25-AD6FC9DD9B65 Q28071916-9ABA3BAC-2C88-4BB6-BEEE-BC0D5E54F422 Q33746529-345D15D2-F0D0-41A3-9D28-56B3F58270CA Q33775712-3A069133-172C-4F0B-B427-E443B7BC0E9B Q34273076-6BA15838-2AF4-4A84-8D17-980EDC916C1C Q35196281-8246E5BF-E4F1-41C4-A1C7-6CFE3202629C Q35203177-8BEC36A0-A274-4C25-AD1E-9E6936A76049 Q35562203-CB6ED49A-0DAC-459F-96C6-EB2781599E77 Q36015654-52FA4E81-1526-4D34-B486-BF8839454004 Q36201380-6C98417F-DC99-492E-BF38-EA8204FD4E9B Q36319925-2478FABB-D1D3-4996-977F-79956163E326 Q36465085-0689BA86-928B-4F2E-B8A5-DE827CEDC8E6 Q36702970-B0048D1C-4E5E-4FB4-A977-B2B9C9C0BA2B Q36762289-EB3F53DA-1756-4970-9EB6-A0F0611E042D Q36911124-427CD158-5FFD-4EB3-ACFD-FABBF778F358 Q36930148-37455C97-1B7D-4120-A8F4-8724C10C5AE5 Q36995514-A859C176-C42D-4DF2-952D-E49E23B1E62B Q37466512-13597872-DFE6-479C-AEF3-1BD482B87038 Q38069060-182E185C-7EC0-47DF-B488-2D0680C1A639 Q38162181-3947B102-C7C9-460E-8FA9-194B3B85F095 Q38167313-631C0A9F-1EED-4696-AA43-4237176F80AC Q38205430-82D1D70D-C0A8-43E4-8462-5077CF16C34F Q38255419-DFA853D9-C316-497E-9976-F9D194772012 Q38767261-10630D64-23D8-4B6D-B7BE-DDBD4104D9ED Q38943709-2A92C729-7312-4D51-B68A-6A110BA693A3 Q38983878-82A8BCDF-EE91-43A7-8C4B-5F0CE7249669 Q39175513-3E2F91C7-6AF0-468F-97FE-49E4B99E53C0 Q39198131-0731B0E1-483F-45D8-9268-6DB799139BD2 Q41066068-1C72E9B8-8477-41C0-8859-D0BCC85BE2E9 Q41706699-56D8A4C7-2765-4F0D-9FC8-160FA8DB7F25 Q41898034-D67D399F-8CA2-4D74-AD78-4BD8C70829C6 Q42045184-A63C7646-E36B-4D79-A012-21BAAD953BB3 Q42573535-524C1086-B78A-4F84-9CAC-4DB2686C60C6 Q42593149-A21B471E-0E11-4537-9BFF-238B060F52F2 Q42636758-014FBDAE-02F8-46DB-B901-FF6FF0CD6A1D Q42962199-3B3D37AE-3536-4A66-93C4-8FA6F8782CF1

P2860

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

http://www.wikidata.org/entity/Q35166506

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

@ast

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

@en

type

label

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

@ast

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

@en

prefLabel

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

@ast

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

@en

P1433

Q35166506-D162FDC0-C2AF-43E0-87BE-93B8362D2740

P1476

Q35166506-52F47BB7-F21A-4382-8382-8E35C9A31D9F

P2093

Q35166506-04490CEA-F6A6-4EAA-A570-391B529B0D12

Q35166506-13A192CB-8299-46BE-A26D-69F2081E6DBE

Q35166506-2A0ECA2D-B40D-4941-A789-63A1C96FEC91

Q35166506-BEFEA691-16A7-4A15-8415-9108E924C15C

Q35166506-FFDEE9ED-E865-4051-90C4-099A921DA246

P275

Q35166506-F2AE24D2-FF75-466F-AA60-F7D4509A3386

P2860

Q35166506-01BD201A-C13F-4D84-A403-C0A690AB9039

Q35166506-01ED01FA-7328-4E94-B306-B8BF7E167F87

Q35166506-036B3632-278A-4C09-AA29-095D6AE4F4A8

Q35166506-058A4F86-E7B8-4A3D-8641-136D084498AE

Q35166506-0896972C-54DA-4E4C-8733-6B6E5380B1E3

Q35166506-089E26F6-B54E-4460-8BFF-AF41E925BCD1

Q35166506-099DD18E-CB7D-42CA-930A-6825EAB1B2E0

Q35166506-0BEE3DCC-6120-4936-9E9A-3231B2555ACD

Q35166506-0DAB4639-8F43-41B2-AD93-E526E67EEA9D

Q35166506-0EF5437A-1115-4C5B-856C-CDD1D453A9D3

P2888

Q35166506-B0BCFE41-A826-42EE-9D45-D7C236D790F1

P304

Q35166506-E0E7A113-F22D-4F2B-9599-63FDE38C0C5D

P31

Q35166506-082BFD54-CAAB-4640-ADDA-E6F0EBA6119B

Q35166506-2189582A-D0DE-4922-8A10-B34EE3CC76EB

P356

Q35166506-F141E2C5-EA3B-4638-92F1-CC07F6CADC03

P478

Q35166506-FC092FBF-0F97-41C9-8721-0C8C10993AB3

P577

Q35166506-80B0D101-FDD4-49FC-8D2E-05DEC2BC8728

P5875

Q35166506-57078D65-B679-4128-8742-0C2D5E7C65AB

P6179

Q35166506-A81DA721-05EC-4337-9A66-D2EB9FB48DB2

P698

Q35166506-09C438F6-38B3-4D7C-A98F-C9072546FFA4

P921

Q35166506-01C3A5FB-69C7-413F-958B-8C58C9B45CD5

Q35166506-7A85ECF2-F263-445E-AD0B-DC9C34BE4688

Q35166506-F8D11155-6B0B-4E9B-A3A0-526C030540F9

P932

Q35166506-4A91A053-4A03-40B6-AAD1-B78633E02AD2

P356

1423-0127-18-49

P1433

Journal of Biomedical Science

P1476

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

@en

P2093

B-Linju Yen

http://www.w3.org/2001/XMLSchema#string

Huey-Kang Sytwu

http://www.w3.org/2001/XMLSchema#string

Ko-Jiunn Liu

http://www.w3.org/2001/XMLSchema#string

Men-Luh Yen

http://www.w3.org/2001/XMLSchema#string

Pei-Min Chen

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Human T regulatory cell therapy: take a billion or so and call me in the morning

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

Immunogenicity of Human Mesenchymal Stem Cells in HLA-Class I-Restricted T-Cell Responses Against Viral or Tumor-Associated Antigens

Multilineage potential of adult human mesenchymal stem cells

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Dendritic cells in the T-cell areas of lymphoid organs

Beyond the increasing complexity of the immunomodulatory HLA-G molecule

Human mesenchymal stem cells modulate allogeneic immune cell responses

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells

P2888

1423-0127-18-49

P304

49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1423-0127-18-49

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51495835

http://www.w3.org/2001/XMLSchema#string

P6179

1049720439

http://www.w3.org/2001/XMLSchema#string

P698

21762539

http://www.w3.org/2001/XMLSchema#string

P921

mesenchymal stem cells

embryonic structure

P932

3156728

http://www.w3.org/2001/XMLSchema#string